Expression of RPS19 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPS19 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 4089.32

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

3375.6

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	8110.3
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	7580.2
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	7537.0
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	7257.4
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	6639.2
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	6626.6
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	6418.0
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	6388.3
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	6159.0
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	5672.1
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	5403.9
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	5340.9
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	5297.0
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	5229.0
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	5073.8
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	4948.9
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	4892.2
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	4868.2
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	4854.1
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	4786.3
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	4753.5
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	4640.7
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	4630.6
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	4569.8
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	4347.9
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	4333.7
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	4303.1
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	4266.6
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	4265.1
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	4250.4
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	4203.7
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	4153.7
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	4113.9
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	4112.2
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	4066.4
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	4051.6
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	3999.3
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	3938.4
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	3884.0
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	3873.5
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	3815.6
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	3810.3
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	3758.9
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	3748.1
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	3741.8
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	3702.2
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	3677.9
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	3614.3
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	3613.2
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	3596.9
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	3559.3
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	3536.5
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	3510.0
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	3509.0
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	3463.8
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	3416.6
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	3368.9
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	3350.4
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	3342.3
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	3335.5
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	3296.7
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	3264.2
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	3217.9
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	3205.2
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	3191.4
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	3174.6
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	3172.6
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	3148.6
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	3138.7
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	3137.4
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	3119.6
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	3093.1
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	3080.7
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	3026.3
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	3016.7
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	2978.3
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	2972.0
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	2945.4
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	2928.8
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	2905.7
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	2893.3
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	2890.8
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	2875.2
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	2870.1
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	2859.3
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	2848.8
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	2816.9
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	2810.9
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	2788.3
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	2785.2
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	2751.6
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	2734.6
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	2730.7
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	2716.8
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	2698.3
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	2690.7
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	2681.8
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	2674.2
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	2630.6
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	2578.9
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	2574.2
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	2571.7
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	2560.9
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	2546.5
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	2533.6
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	2531.6
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	2453.5
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	2436.0
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	2372.5
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	2362.0
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	2310.6
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	2306.4
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	2297.6
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	2281.6
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	2243.0
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	2190.2
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	2136.3
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	2120.5
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	2112.5
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	2101.5
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	2096.8
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	2052.3
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	2034.8
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	2013.6
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	2012.5
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1984.7
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1977.6
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	1926.0
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	1850.1
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1833.4
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	1803.8
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1767.3
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	1720.2
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1704.2
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	1541.3
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	1489.1
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	1396.4
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1360.2
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1268.3
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	1234.8
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	1203.4
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPS19 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 345.07

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

381.9

Number of samples

Samples

Sample	Description	pTPM
AK139	N, NA, stage:NA, dead, 270 days	799.8
AK178	N, NA, stage:NA, dead, 240 days	794.7
AK074	N, NA, stage:NA, alive, 300 days	759.5
AK043	N, NA, stage:NA, alive, 660 days	754.0
AK133	N, NA, stage:NA, dead, 360 days	727.2
AK098	N, NA, stage:NA, dead, 660 days	662.6
AK002	N, NA, stage:NA, dead, 570 days	624.4
AK213	N, NA, stage:NA, alive, 2010 days	607.4
AK165	N, NA, stage:NA, alive, 360 days	590.6
AK049	N, NA, stage:NA, dead, 180 days	582.6
AK072	N, NA, stage:NA, dead, 150 days	573.9
AK236	N, NA, stage:NA, dead, 360 days	501.2
AK199	N, NA, stage:NA, alive, 1860 days	487.6
AK053	N, NA, stage:NA, dead, 300 days	481.2
AK183	N, NA, stage:NA, alive, 360 days	470.7
AK055	N, NA, stage:NA, dead, 240 days	444.4
AK185	N, NA, stage:NA, alive, 330 days	435.8
AK231	N, NA, stage:NA, dead, 240 days	433.5
AK142	N, NA, stage:NA, alive, 90 days	431.4
AK188	N, NA, stage:NA, alive, 420 days	423.7
AK088	N, NA, stage:NA, dead, 360 days	418.3
AK100	N, NA, stage:NA, alive, 960 days	388.4
AK123	N, NA, stage:NA, dead, 180 days	383.2
AK158	N, NA, stage:NA, dead, 360 days	359.6
AK066	N, NA, stage:NA, alive, 960 days	352.5
AK068	N, NA, stage:NA, alive, 360 days	345.9
AK089	N, NA, stage:NA, dead, 330 days	344.2
AK167	N, NA, stage:NA, dead, 180 days	341.1
AK117	N, NA, stage:NA, dead, 210 days	338.9
AK071	N, NA, stage:NA, dead, 540 days	331.6
AK153	N, NA, stage:NA, dead, 240 days	327.4
AK134	N, NA, stage:NA, dead, 360 days	327.4
AK156	N, NA, stage:NA, dead, 330 days	303.5
AK149	N, NA, stage:NA, dead, 420 days	300.2
AK216	N, NA, stage:NA, dead, 360 days	294.8
AK076	N, NA, stage:NA, alive, 660 days	281.6
AK035	N, NA, stage:NA, dead, 210 days	280.9
AK091	N, NA, stage:NA, dead, 210 days	280.6
AK124	N, NA, stage:NA, alive, 1920 days	270.0
AK041	N, NA, stage:NA, alive, 810 days	269.9
AK195	N, NA, stage:NA, dead, 390 days	266.4
AK103	N, NA, stage:NA, alive, 1320 days	265.8
AK099	N, NA, stage:NA, dead, 420 days	258.5
AK226	N, NA, stage:NA, dead, 360 days	253.1
AK079	N, NA, stage:NA, dead, 210 days	252.1
AK081	N, NA, stage:NA, dead, 180 days	249.2
AK218	N, NA, stage:NA, dead, 180 days	241.6
AK051	N, NA, stage:NA, dead, 360 days	236.5
AK173	N, NA, stage:NA, dead, 180 days	228.3
AK030	N, NA, stage:NA, dead, 120 days	217.3
AK227	N, NA, stage:NA, alive, 300 days	214.1
AK205	N, NA, stage:NA, dead, 120 days	210.9
AK085	N, NA, stage:NA, alive, 660 days	203.5
AK015	N, NA, stage:NA, alive, 720 days	196.1
AK003	N, NA, stage:NA, dead, 600 days	195.0
AK102	N, NA, stage:NA, alive, 1740 days	188.4
AK005	N, NA, stage:NA, dead, 240 days	186.6
AK006	N, NA, stage:NA, dead, 360 days	164.0
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0127480003	Tumor	0.9
CPT0206560003	Tumor	0.8
CPT0224390004	Tumor	0.7
CPT0218330004	Tumor	0.6
CPT0206000004	Tumor	0.6
CPT0218690004	Tumor	0.6
CPT0217710008	Tumor	0.5
CPT0093450003	Tumor	0.5
CPT0093360003	Tumor	0.5
CPT0168080003	Tumor	0.5
CPT0161730003	Tumor	0.5
CPT0123530003	Tumor	0.4
CPT0217430008	Tumor	0.4
CPT0207090003	Tumor	0.4
CPT0078580003	Tumor	0.4
CPT0168830003	Tumor	0.4
CPT0167530003	Tumor	0.4
CPT0093590003	Tumor	0.3
CPT0182580003	Tumor	0.3
CPT0206670004	Tumor	0.3
CPT0206780003	Tumor	0.3
CPT0127420003	Tumor	0.3
CPT0228220003	Tumor	0.3
CPT0205450004	Tumor	0.2
CPT0205670004	Tumor	0.2
CPT0217880003	Tumor	0.2
CPT0224540004	Tumor	0.2
CPT0217190003	Tumor	0.2
CPT0125220003	Tumor	0.2
CPT0217060003	Tumor	0.2
CPT0125570003	Tumor	0.2
CPT0167860004	Tumor	0.2
CPT0093510003	Tumor	0.2
CPT0218960004	Tumor	0.2
CPT0167970003	Tumor	0.2
CPT0225760003	Tumor	0.1
CPT0167750004	Tumor	0.1
CPT0189850004	Tumor	0.1
CPT0217100003	Tumor	0.1
CPT0064650003	Tumor	0.1
CPT0002410011	Tumor	0.1
CPT0089150003	Tumor	0.1
CPT0206230003	Tumor	0.1
CPT0218770003	Tumor	0.1
CPT0218830004	Tumor	0.1
CPT0189750004	Tumor	0.1
CPT0190360004	Tumor	0.1
CPT0225730003	Tumor	0.1
CPT0171580008	Tumor	0.1
CPT0205780003	Tumor	0.1
CPT0168480003	Tumor	0.1
CPT0079790003	Tumor	0.1
CPT0224600003	Tumor	0.1
CPT0218890004	Tumor	0.1
CPT0182500003	Tumor	0.0
CPT0221180003	Tumor	0.0
CPT0168590003	Tumor	0.0
CPT0201710003	Tumor	0.0
CPT0071100003	Tumor	0.0
CPT0064890003	Tumor	0.0
CPT0087680003	Tumor	0.0
CPT0093550003	Tumor	0.0
CPT0175060003	Tumor	0.0
CPT0189570004	Tumor	0.0
CPT0216920008	Tumor	0.0
CPT0207030003	Tumor	0.0
CPT0087570003	Tumor	-0.1
CPT0218670003	Tumor	-0.1
CPT0168720003	Tumor	-0.1
CPT0189650004	Tumor	-0.1
CPT0087950003	Tumor	-0.1
CPT0205570003	Tumor	-0.1
CPT0209440003	Tumor	-0.1
CPT0104330003	Tumor	-0.1
CPT0162140003	Tumor	-0.1
CPT0168270003	Tumor	-0.1
CPT0167640003	Tumor	-0.1
CPT0186100003	Tumor	-0.1
CPT0189460003	Tumor	-0.2
CPT0125510003	Tumor	-0.2
CPT0199770003	Tumor	-0.2
CPT0206330003	Tumor	-0.2
CPT0206110003	Tumor	-0.2
CPT0162020003	Tumor	-0.2
CPT0189250003	Tumor	-0.2
CPT0092440003	Tumor	-0.2
CPT0206450003	Tumor	-0.2
CPT0224330003	Tumor	-0.2
CPT0168380003	Tumor	-0.2
CPT0205890003	Tumor	-0.2
CPT0206880003	Tumor	-0.2
CPT0204360003	Normal	-0.2
CPT0182550003	Tumor	-0.3
CPT0219080004	Tumor	-0.3
CPT0087730003	Tumor	-0.3
CPT0204340003	Normal	-0.3
CPT0208980003	Tumor	-0.3
CPT0190240004	Tumor	-0.3
CPT0204400003	Normal	-0.3
CPT0204330003	Normal	-0.4
CPT0104220003	Tumor	-0.4
CPT0204410003	Normal	-0.4
CPT0204380003	Normal	-0.4
CPT0196850003	Tumor	-0.5
CPT0204350003	Normal	-0.5
CPT0204420003	Normal	-0.5
CPT0204370003	Normal	-0.5
CPT0204390003	Normal	-0.6
CPT0217000004	Tumor	-0.7
CPT0162100003	Tumor	-0.7
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis